Combined PET/CT Scanning Can Change the Management of High-Risk Cancers
|
By MedImaging International staff writers Posted on 14 Dec 2015 |
|
The results of a new study show that PET/CT and whole body MRI scanning can be used to change the management of high-risk breast and prostate cancer patients.
The study was published in the December 2015, issue of the Journal of Nuclear Medicine and indicated that Positron Emission Tomography/Computed Tomography (PET/CT) and whole-body Magnetic Resonance Imaging (MRI) could detect extra-skeletal disease and change the management of high-risk breast and prostate cancer patients. The administration of F-18 sodium fluoride (NaF) and F-18 fluorodeoxyglucose (FDG) in a single PET/CT scan also provided significantly higher accuracy, and sensitivity for the detection of skeletal lesions.
The study group consisted of patients with breast or prostate cancers and compared results of the combined use of F-18 NaF/F-18 FDG PET/CT, to those obtained with Tc-99m MDP Bone Scintigraphy (BS) and Whole-Body MRI (WBMRI). The study included 15 women with breast cancer, and 15 men with prostate cancer that had been referred for standard of care BS and subsequently underwent NaF/FDG PET/CT and WBMRI. According to the results of the preliminary study NaF/FDG PET/CT was significantly more accurate in detecting skeletal lesions than WBMRI and Tc-99m MDP scintigraphy, and NaF/FDG PET/CT and WBMRI were able to detect extra-skeletal disease, and could change the way high-risk breast and prostate cancer patients treatment are managed.
Corresponding author of the study Andrei H. Iagaru, MD, FACNM, co-chief of the Stanford University (Stanford, CA, USA) division of Nuclear Medicine and Molecular Imaging, and co-director of the PET-MRI research program, said, "Using results from previous studies, this project attempts to identify the most appropriate approach for identifying lesions in selected breast and prostate cancer patients who are at high risk of developing metastatic disease. More work remains to be done, and our group is now exploring the use of combined NaF/FDG injections with state of the art PET/MRI technology for significant decreases in radiation exposure and improved diagnostic performance in accurately evaluating extent of disease in cancer patients.”
Related Links:
Stanford University
The study was published in the December 2015, issue of the Journal of Nuclear Medicine and indicated that Positron Emission Tomography/Computed Tomography (PET/CT) and whole-body Magnetic Resonance Imaging (MRI) could detect extra-skeletal disease and change the management of high-risk breast and prostate cancer patients. The administration of F-18 sodium fluoride (NaF) and F-18 fluorodeoxyglucose (FDG) in a single PET/CT scan also provided significantly higher accuracy, and sensitivity for the detection of skeletal lesions.
The study group consisted of patients with breast or prostate cancers and compared results of the combined use of F-18 NaF/F-18 FDG PET/CT, to those obtained with Tc-99m MDP Bone Scintigraphy (BS) and Whole-Body MRI (WBMRI). The study included 15 women with breast cancer, and 15 men with prostate cancer that had been referred for standard of care BS and subsequently underwent NaF/FDG PET/CT and WBMRI. According to the results of the preliminary study NaF/FDG PET/CT was significantly more accurate in detecting skeletal lesions than WBMRI and Tc-99m MDP scintigraphy, and NaF/FDG PET/CT and WBMRI were able to detect extra-skeletal disease, and could change the way high-risk breast and prostate cancer patients treatment are managed.
Corresponding author of the study Andrei H. Iagaru, MD, FACNM, co-chief of the Stanford University (Stanford, CA, USA) division of Nuclear Medicine and Molecular Imaging, and co-director of the PET-MRI research program, said, "Using results from previous studies, this project attempts to identify the most appropriate approach for identifying lesions in selected breast and prostate cancer patients who are at high risk of developing metastatic disease. More work remains to be done, and our group is now exploring the use of combined NaF/FDG injections with state of the art PET/MRI technology for significant decreases in radiation exposure and improved diagnostic performance in accurately evaluating extent of disease in cancer patients.”
Related Links:
Stanford University
Silver Member
X-Ray QA Meter
T3 AD Pro
New
Digital Intelligent Ferromagnetic Detector
Digital Ferromagnetic Detector
Wall Fixtures
MRI SERIES
X-Ray Illuminator
X-Ray Viewbox Illuminators
Latest Nuclear Medicine News
- Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
- Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
- Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
- Innovative PET Imaging Technique to Help Diagnose Neurodegeneration
- New Molecular Imaging Test to Improve Lung Cancer Diagnosis
- Novel PET Technique Visualizes Spinal Cord Injuries to Predict Recovery
- Next-Gen Tau Radiotracers Outperform FDA-Approved Imaging Agents in Detecting Alzheimer’s
- Breakthrough Method Detects Inflammation in Body Using PET Imaging
- Advanced Imaging Reveals Hidden Metastases in High-Risk Prostate Cancer Patients
- Combining Advanced Imaging Technologies Offers Breakthrough in Glioblastoma Treatment
- New Molecular Imaging Agent Accurately Identifies Crucial Cancer Biomarker
- New Scans Light Up Aggressive Tumors for Better Treatment
- AI Stroke Brain Scan Readings Twice as Accurate as Current Method
- AI Analysis of PET/CT Images Predicts Side Effects of Immunotherapy in Lung Cancer
- New Imaging Agent to Drive Step-Change for Brain Cancer Imaging
- Portable PET Scanner to Detect Earliest Stages of Alzheimer’s Disease
Channels
Radiography
view channel
AI Improves Early Detection of Interval Breast Cancers
Interval breast cancers, which occur between routine screenings, are easier to treat when detected earlier. Early detection can reduce the need for aggressive treatments and improve the chances of better outcomes.... Read more
World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. Made of carbon with an atomic number of six, diamonds... Read more
Ultrasound
view channel.jpeg "Image: The AI-powered lung ultrasound tool outperformed human experts by 9% in diagnosing TB (Photo courtesy of Adobe Stock)")
AI-Powered Lung Ultrasound Outperforms Human Experts in Tuberculosis Diagnosis
Despite global declines in tuberculosis (TB) rates in previous years, the incidence of TB rose by 4.6% from 2020 to 2023. Early screening and rapid diagnosis are essential elements of the World Health... Read more
AI Identifies Heart Valve Disease from Common Imaging Test
Tricuspid regurgitation is a condition where the heart's tricuspid valve does not close completely during contraction, leading to backward blood flow, which can result in heart failure. A new artificial... Read more
Nuclear Medicine
view channel
Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more
Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
COX-2, an enzyme that plays a key role in brain inflammation, can be significantly upregulated by inflammatory stimuli and neuroexcitation. Researchers suggest that COX-2 density in the brain could serve... Read more
General/Advanced Imaging
view channel
CT-Based Deep Learning-Driven Tool to Enhance Liver Cancer Diagnosis
Medical imaging, such as computed tomography (CT) scans, plays a crucial role in oncology, offering essential data for cancer detection, treatment planning, and monitoring of response to therapies.... Read more
AI-Powered Imaging System Improves Lung Cancer Diagnosis
Given the need to detect lung cancer at earlier stages, there is an increasing need for a definitive diagnostic pathway for patients with suspicious pulmonary nodules. However, obtaining tissue samples... Read more
Imaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read more
Industry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more